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1. Introduction 
Leucocytes undergo a dramatic increase in respira- 
tion during phagocytosis or upon perturbation of the 
plasma membrane with a variety of soluble factors. 
This ‘respiratory burst’ results in the production of 
large quantities of superoxide anion (O;), of H,Oz 
and indirectly of OH’ and singlet oxygen [ 1,2]. This 
impressive phenomenon, which is relevant for the kill- 
ing activity against invading organisms [ 1,3,4] and 
against tumor cells [5], is triggered by the interaction 
of the stimulatory agents with appropriate receptors 
or binding sites in the plasma membrane [2]. The 
ensuing molecular modification of the plasma mem- 
brane leads to activation of a piridine nucleotide 
oxidase that utilizes NADPH as a physiological sub- 
strate [2]. 
We have investigated the mechanism that triggers 
the respiratory burst by using concanavalin A (con A) 
shown [6] to stimulate the metabolic activity of leu- 
cocytes through a modification of the plasma mem- 
brane which follows the interaction of the lectin with 
the cell surface receptors [6,7]. In the course of that 
investigation we showed that cytochalasin B (CB) 
potentiates the respiratory response of guinea pig and 
rabbit polymorphonuclear leucocytes (PMN) and of 
rabbit alveolar macrophages to con A [8,9]. A simi- 
lar effect of CB on rabbit PMN stimulated by the 
chemotactic peptide formyl-methionyl-leucyl- 
phenylalanine (FMLP) and by the calcium ionophore 
A23 187 has been shown in [ 10,111. 
This paper deals with the mechanisms underlying 
the effect of CB and reports data showing that the 
drug acts by increasing the activation of the NADPH 
oxidase, the plasma membrane-bound enzyme respon- 
sible for the respiratory burst of leucocytes. 
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2. Materials and methods 
Con A, cytochrome c (type VI), superoxide dis- 
mutase (SOD) (type I), a-methyl-D-mannoside 
(a-MM) (grade III) and NADPH (grade III) were pur- 
chased from Sigma Chemical Co. (St Louis, MO); 
[3H]con A was purchased from New England Nuclear 
(Dreieich); cytochalasin B purchased from Serva 
(Heidelberg) was dissolved in dimethylsulfoxide 
(DMSO) at 5 mg/ml final cont. Other chemicals were 
of reagent grade. 
2.1. Cells 
Guinea pig PMN from peritoneal exudate were 
obtained as in [ 121. Human PMN were isolated from 
blood, taken from normal donors, by dextran sedi- 
mentation of red cells and centrifugation of the leu- 
cocyte-rich fraction on Ficoll-Paque (Pharmacia, 
Uppsala). Cells were freed from contaminating eryth- 
rocytes by a brief hypotonic shock and suspended in 
Krebs Ringer phosphate buffer (pH 7.4) containing 
5 mM glucose and 0.5 mM CaClz (KRP). Both guinea 
pig and human cell suspensions were composed of 
90-95s neutrophils. 
2.2. Oxygen consumption 
Cell respiration was monitored by a Clark-type 
oxygen electrode attached to a thermostatically con- 
trolled plastic vessel (37”C), using 1.5-2 X IO’ cells 
in 2 ml KRP. To avoid inactivation of the NADPH 
oxidase the incubation medium contained 2 mM 
NaN, [13]. 
2.3. Superoxide release 
0; release was measured by the superoxide-inhib- 
itable reduction of cytochrome c [12,14] either by 
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continuous monitoring or in the same experimental 
conditions used to measure the oxygen uptake. In the 
former case the assay medium contained 1 ml KRP, 
2.5 X lo6 PMN, 100 PM cytochrome c, 2 mM NaN,; 
con A (100 ,ug/ml) and SOD (2.5 pg/ml) were added 
where required and the reduction of cytochrome c 
was measured at 550 nm in a 576 Perkin Elmer spec- 
trophotometer at 37°C. In the other case 0; was 
measured, as in [ 121, on samples withdrawn from the 
electrode vessel, where oxygen uptake was continu- 
ously recorded, 4 min after the addition of the stimu- 
lant. The assay medium was composed of 2 ml KRP, 
2 X lo7 cells, 2 mM NaN,, 200 FM cytochrome c 
and, when necessary, 50 pg SOD. 
2.4. NADPHiIependent 0; producing activity 
(NADPH oxidase) in cell free particles 
After the measurement of oxygen consumption 
guinea pig PMN were withdrawn from the electrode 
chamber, 5-fold diluted with ice cold KRP, washed, 
resuspended in 0.34 M sucrose (pH 7.0) containing 
1 mM NaHC03, disrupted by sonication (MSE soni- 
fier) and assayed for NADPH-dependent 0; produc- 
ing activity by monitoring the SOD-inhibitable reduc- 
tion of cytochrome c at 550 nm (Perkin Elmer 576) 
asin [15]. 
2.5. Lectin binding 
A solution of [3H]con A at 4 mg/ml lectin (spec. 
act. 2300 cpm/pg lectin) was used. The assay was car- 
ried out simultaneously with the measurement of 
oxygen uptake. CB (5 pg/ml) or DMSO 0.1% were 
added to 1.5-2 X 10’ PMN in 2 ml KRP containing 
2 mM NaN,; the mixture was incubated 3 min at 
37°C. After this time the resting respiration was 
recorded and 2 min thereafter 100 pgg/ml labeled 
con A were added. After 3 min (when the stimulated 
respiration reached its maximum value, either in the 
presence or in the absence of CB) 1 ml and 0.5 ml of 
the cell suspension were withdrawn and rapidly 
diluted in 9 or 9.5 ml chilled KRP, respectively. The 
cells were then spun down for 5 min at 400 X g at 
O”C, washed with 10 ml KRP and pelletted (400 X g, 
5 min). The cell pellets were dissolved in 10 ml scin- 
tillation medium composed of 300 ml Triton X-100 
(Merck, Darmstadt, scintillation grade), 700 ml toluol 
and 5.5 g Permablend III (Packard Instrument Co., 
Downers Grove, IL) and counted in a Beckman 
LS-100 liquid scintillation counter. 
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3. Results and discussion 
3.1. Ejyect oj’CB OIZ the oxl*gerl uptake of PMN 
stimuluted by con A 
Fig.1 shows the effect of CB on the extra respira- 
tion induced by con A on guinea pig PMN. It can be 
seen that: 
(i) The drug causes a marked potentiation of the 
stimulatory response to con A; 
(ii) Both the extra respiration induced by con A and 
by con A + CB are reversed by a-MM; 
(iii) CB induces a slight increase of O2 consumption 
also when added alone. 
The effect of CB is dose-dependent being already 
marked at 1 /&ml and reaching a plateau at 10 pg/ml 
(not shown). The drug is active in a wide range of 
concentrations of con A (20-300 /*g/ml). 
3.2. Effect of CB on the 0; release from PA4N 
stimulated by con A 
The 0, formed during the respiratory burst is 
measured by the reduction of cytochrome c. Since 
this compound does not enter into the cell the 0; 
measured corresponds only to the amount of the rad- 
ical that is released from the cell into the external 
medium. This amount is only a part of the 0; formed 
by the stimulated cells [ 12,16,17]. Fig.2 shows the 
effect of CB on the respiratory burst of PMN induced 
by con A, assayed as continuous monitoring of 0; 
release. It can be seen that: 
(i) The addition of CB on resting PMN increases the 
0; production, the increment taking place imme- 
diately after the addition of the drug; 
DMSO co? A 
Fig.1. Effect of cytochalasin B on the oxygen uptake by 
guinea pig PMN stimulated with concanavalin A (con A): CB 
(10 IJ~ in 2 ~1 DMSO) or 2 ctl DMSO were added 5 min before 
con A (200 w(g in 50 ~1 KRP); a-MM was 70 mM. 
Volume 125, number 2 FEBS LETTERS March 1981 
Fig.2. Continuous monitoring of 0; release from cytochala- 
sin B-treated guinea pig PMN: CB, 5 fig/ml; con A, 100 fig/ml 
For experimental details see section 2. 
(ii) Con A causes an increase of 0; production after 
a lag time of 70-80 s; 
(iii) Con A added to cells pretreated with CB induces 
a stimulation of 0; production much greater 
than that induced by con A alone. 
To investigate whether the increased recovery of 0; 
in the extracellular medium caused by CB is due to 
the enhanced formation of the radicals and also to an 
increased diffusion through the plasma membrane we 
have studied the effect of the drug by comparing the 
increment of 0; released outside the cells with that 
of 0, consumption. The results reported in table 1 
show that: 
(i) CB added alone induces a slight but significant 
increase in O2 consumption and 0, recovery. If 
we consider the ratio O;/O, we can see that, for 
every nmol oxygen consumed, CB-treated cells 
release 1 .OS nmol 0; and control cells release 
0.4 1 nmol0;. Taking into account the extra res- 
piration induced by CB for every nmol O2 con- 
sumed, 3 .O nmol0; are released. These data 
seem to indicate that CB induces in resting cells 
both an increase in O2 consumption and an 
increase in the proportion of 0; that is recovered 
outside the cells; 
CB potentiates both the increase of O2 uptake 
and of 0; release by con A-treated cells. Taking 
into account the extra O2 uptake and the extra 
0; release it can be seen that the ratio OJO, 
approximates to unity both in the presence and 
in the absence of CB, indicating that in con A- 
treated cells CB does not modify the proportion 
of 0; which is released with respect to the 
amount which is formed. These findings demon- 
strate that the greater recovery of 0; outside the 
cells when they are stimulated by con A in the 
presence of CB, is not linked to an increased dif- 
fusion of the radical through the plasma mem- 
brane. 
Effect of CB on the NADPH oxidase activity 3.3 
Table 1 
0, uptake and 0; release by CB-treated guinea pig PMN 
To get a better insight into the effect of CB we 
have investigated the action of the drug on the activa- 
tion of the membrane-bound NADPH oxidase, that is 
the main event responsible for the respiratory burst. 
The data of table 2 shows that: 
(i) Cell-free particles of cells treated with CB present 
a higher activity of NADPH oxidase. This indi- 
cates that the binding of this drug to the cell 
membrane represents ‘per se’ a signal for the 
activation of the NADPH oxidase, as has been 
(ii) 
Resting cells Con A-treated cells Average increment 
induced by con A 
0, 0; o;/o, 0, 0; 0, 0; o;/o, 
Control 28.0 + 3.0 (10) 11.4 * 4.0 (6) 0.41 94.4 r 9.4 (10) 74.6 + 11.2 (6) 66.4 63.2 0.95 
CB 37.3 + 5.5 (10) 39.4 + 8.0 (6) 1.05 136.2 + 15.2 (10) 138.6 + 19.8 (6) 98.9 98.6 1.02 
P < 0.005 P < 0.025 P < 0.001 P < 0.025 
A” 9.3 28.0 3.0 
a CB minus control that is the extra respiration induced by CB 
Values are expressed as nmol 2 X 10’ cell-’ .4 mine’ f SEM. Experimental details are in section 2: con A, 100 @g/ml; CB, 
5 fig/ml; DMSO, 0.1%. P was calculated by Student’s f-test on paired data; expt in brackets 
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Table 2 
Effect of CB on the NADPHoxidase activity of subcellular 
particles from resting and con A-treated guinea pig PMN 
_.-__ 
Additions (nmol min.’ mg protein’) ? SEM 
DMSO CB 
None 2.6 + 0.2 (7) 3.4 i 0.4 (7) 
P < 0.05 
Con A 9.0 * 1.2 (10) 22.8 i 3.8 (5) 
Con A + ol-MMa 3.8 f 0.5 (6) 4.2 (2) 
a a-MM was added 2 min after the addition of the lectin, 
when the cell reached the maximal activation. Experimental 
details are in section 2: con A, 100 &ml; CB, 5 Ng/ml; 
DMSO, 0.1%; a-MM, 70 mM. P was calculated by Student’s 
f-test on paired data; no. expt in brackets 
shown for other members of the cytochalasin 
family [ 18 1; 
(ii) CB potentiates the activation of the oxidase 
induced by con A; 
(iii) The activation of the enzyme is reversible. In fact 
when o-MM is added to cells stimulated by con A 
or con A plus CB, during the linear phase of the 
respiratory excitation, the activity of the 
NADPH oxidase resumes its resting value. 
These results demonstrate that the action of CB con- 
sists in an actual increase of the responsiveness of leu- 
cocytes to the stimulatory agent and that the target 
of the drug is the mechanism of the activation of the 
NADPH oxidase in intact PMN. When added to cell 
free particles from either resting or stimulated PMN, 
CB does not modify the activity of the oxidase (not 
shown). 
3 4. Effect of CB on the interaction between the 
lectin and the PMN plasma membrane 
On the basis of the different effect of native and 
dimeric lectin, on the enhancing effect of anti-con A 
antibodies [7] and on the reversibility of the respira- 
tory burst following the displacement, by o-MM, of 
the lectin molecules from their receptors on the 
plasma membrane, we have suggested that the trigger- 
ing of the metabolic stimulation is due to the ligand- 
receptor interaction followed by redistribution of the 
ligand-receptor complexes on the cell surface and 
that the metabolic stimulation would be proportional 
to the extent of receptor crosslinkage induced by the 
lectin [6,7]. Thus the greater responsiveness of the 
NADPH oxidase caused by CB might be explained in 
terms of an increase of the binding of con A to leuco- 
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cyte plasma membrane. We have tested this possibil- 
ity and the first two experiments show that CB 
did not modify the binding of con A. During this 
phase of our work it was shown [ 191 that, in human 
PMN, CB increased the binding of the lectin to cell 
receptors. These results prompted us to continue the 
experiments on the effects of CB on the binding of 
con A by using both the cell types. Table 3 shows 
that guinea pig neutrophils bind virtually the same 
amount of lectin either in the presence or in the 
absence of CB. On the contrary CB increases the 
binding of con A to the cell surface of human poly- 
morphs. These findings indicate that the effect of CB 
on the respiratory burst and on the extent of con A- 
binding can be unrelated phenomena. At least in 
guinea pig PMN the effect of CB on the respiratory 
burst is not due to a greater binding of the lectin to 
the cell receptors. This conclusion is consistent with 
the data in [ 1 l] on the enhancing effect of CB on 
lysosomal enzyme release and on superoxide produc- 
tion by rabbit PMN stimulated with FMLP. 
On the basis of these findings we suggest hat CB 
exerts its action by modifying the molecular events 
that occur after the binding of the lectin to cell recep- 
tors on the plasma membrane. The nature of this mod- 
ification can be only a matter of speculation. In gen- 
eral terms it can be said that the drug facilitates 
and/or accelerates the molecular modifications of the 
plasma membrane that trigger or that are the signals 
for, the activation of the NADPH oxidase, such as ion 
fluxes across the PMN plasma membrane [lo], the 
Table 3 
Effect of cytochalasin B on the binding of con A to guinea 
pig and human PMN 
_____ 
Guinea pig PMN (6) Human PMN (4) 
Con A t DMSO 0.315 ? 0.030 0.244 + 0.030 
P < 0.05 
+CB 0.317 + 0.028 0.343 i 0.060 
+ DMSO t a-MMa 0.065 t 0.020 0.053 + 0.010 
+ CB + a-MM” 0.077 + 0.021 0.060 * 0.013 
a The amounts of lectin bound in the presence of or-MM are 
rcportcd to show the specificity of the con A binding; in 
the presence of o-MM con A was unable to stimulate the 
PMN metabolism 
Values are expressed as @g con A/lo6 cells. The means t SEM 
are reported. Experimental details are in section 2: con A, 
100 pg/ml; CB, 5 @g/ml; DMSO, 0.1%; IX-MM, 70 mM. P was 
calculated by Student’s I-test on paired data; no. expt in 
brackets 
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aggregation of glycoproteins in the plane of the 
membrane [20] and the assembly of the postulated 
subunits of the oxidase system [21]. 
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